A Study for Management of Ocular Side Effects in Subjects with EGFR-Amplified Glioblastoma receiving Depatuxizumab Mafodotin
Clinical Trial Grant
Awarded By
AbbVie Inc.
Start Date
September 26, 2018
End Date
September 30, 2020
Awarded By
AbbVie Inc.
Start Date
September 26, 2018
End Date
September 30, 2020